Credit Suisse Maintains Outperform on BWX Technologies, Raises Price Target to $67
Credit Suisse analyst Scott Deuschle maintains BWX Technologies (NYSE:BWXT) with a Outperform and raises the price target from $65 to $67.
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell
• ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Maxim Group Maintains Buy on BWX Technologies, Raises Price Target to $70
Maxim Group analyst Tate Sullivan maintains BWX Technologies (NYSE:BWXT) with a Buy and raises the price target from $65 to $70.
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
BWXT Technologies Closes Amended And Restated Credit Agreement With Wells Fargo Bank, N.a. And Other Lenders That Increases The Company’s Liquidity While Improving A Number Of Key Terms
BWX Technologies, Inc. (NYSE:BWXT) announced today that it has closed on an amended and restated credit agreement with Wells Fargo Bank, N.A. and other lenders that increases the company's liquidity while improving a
Credit Suisse Picks 7 Aerospace, Defense Stocks To Buy — And 4 To Avoid
Aerospace and defense stocks have been among the handful of investments that have performed well in a very difficult market in 2022.
BWX Technologies’s Return On Capital Employed Overview
According to Benzinga Pro, during Q2, BWX Technologies (NYSE:BWXT) earned $74.68 million, a 26.42% increase from the preceding quarter. BWX Technologies also posted a total of $554.00 million in sales, a 4.33% increase since Q1.
BWXT Medical Executes Commercial Agreement With Bayer For Supply Of Actinium-225 Based Products
BWX Technologies, Inc. (NYSE:BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225).
Today’s announcement